The role of anti-IL-2 receptor in high-risk kidney transplant patients. [electronic resource]
Producer: 20050414Description: 2110-2 p. digitalISSN:- 0041-1345
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Basiliximab
- Daclizumab
- Disease-Free Survival
- Female
- Follow-Up Studies
- Graft Rejection -- epidemiology
- Graft Survival -- immunology
- Histocompatibility Testing
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- immunology
- Living Donors
- Male
- Receptors, Interleukin-2 -- antagonists & inhibitors
- Recombinant Fusion Proteins -- therapeutic use
- Reoperation -- statistics & numerical data
- Retrospective Studies
- Spouses
- Survival Analysis
- Thailand
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.